Septo-optic dysplasia

Clinical trials for Septo-optic dysplasia explained in plain language.

Never miss a new study

Get alerted when new Septo-optic dysplasia trials appear

Sign up with your email to follow new studies for Septo-optic dysplasia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Hope for hypothalamic obesity: daily shot targets weight and hunger

Disease control Recruiting now

This phase 3 trial tests whether a daily injection of setmelanotide can help people aged 4 and older with hypothalamic obesity lose weight and feel less hungry. Participants will receive either the drug or a placebo for 26 weeks. The study aims to see if the treatment leads to me…

Matched conditions: SEPTO-OPTIC DYSPLASIA

Phase 3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC

Septo-optic dysplasia

Get alerted when new Septo-optic dysplasia trials appear

Hope for hypothalamic obesity: daily shot targets weight and hunger